rhTSH-aided Low-Activity Versus High-Activity Regimens of Radioiodine in Residual Ablation for Differentiated Thyroid Cancer
Nuclear Medicine Communications - United States
doi 10.1097/mnm.0b013e328365ac05
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2013
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)